Bill Guilliouma

How Digital Medical Devices Are Meeting the Challenges Of Clinical Trials

By Bill Guilliouma | July 1, 2021
Posted in , , , ,

The Internet of Things (IoT) – defined simply as a system of internet-connected devices that collect and transfer data over a wireless network – has transformed healthcare, from electronic health… Read More »

Noble Further Expands Capabilities of Its New Human Factors + Program

By Bill Guilliouma | June 8, 2021
Posted in ,

HF+ gaining momentum with additional offerings, successful support for new drug launches and expert hiring ORLANDO, Fla. (June 8, 2021) – In direct response to the rapid growth of the… Read More »

Noble/Aptar Pharma Digital Health Webinar

By Bill Guilliouma | June 4, 2021
Posted in , , ,

Joint Webinar from Noble & Aptar Pharma Discusses How to Improve Patient Adherence and Compliance With Innovative Digital Healthcare Solutions Hear from Adam Shain, Business Development Director, Digital Healthcare, Aptar… Read More »

The Critical Role of Training in The Use Of Nasal Rescue Therapies

By Bill Guilliouma | May 18, 2021
Posted in , , , , , , , , , , , , , , , , ,

Startling statistics have revealed the magnitude of the global opioid epidemic. According to the World Health Organization (WHO), in 2018 about 58 million people worldwide used opioids, and another 35.6… Read More »

Human Factors + Webinar: Regulatory Overview

By Bill Guilliouma | May 17, 2021
Posted in

Part 1 of Noble’s Human Factors + Webinar Series: Regulatory Overview Join Noble’s Joe Reynolds and Joe Masci, along with Human Factors expert Kevin Cluff, in the first of our… Read More »

Noble Further Expands Its Human Factors Expertise with Two New Hires for Newly Created HF-Focused Positions

By Bill Guilliouma | May 13, 2021
Posted in

According to the US FDA, human factors engineering is an essential component of product development for drug delivery and medical devices. The US FDA recommends making it a robust part… Read More »